Medicare prior authorization · 64581

64581Sacral Nerve Stimulation for Urinary Incontinence

Subject to WISeR prior authorization or pre-payment review in AZ, NJ, OH, OK, TX, WA for dates of service 2026-01-15 through 2031-12-31, in hospital outpatient, ambulatory surgical center, office and home settings. The decision is made on Medicare’s existing coverage policy; nothing in these programs changes what is covered.

WISeR

Decision
3 days; 2 days expedited; unlimited resubmissions
If no request is made
the claim goes to pre-payment medical review
Policies CMS cites (Appendix A)
NCD 230.18
Participant by state
AZ: Zyter · NJ: Genzeon · OH: Innovaccer · OK: Humata Health · TX: Cohere Health · WA: Virtix Health
Exemption
NPI-level, after ≥10 requests and the participant’s affirmation-rate threshold in an assessment period; granted quarterly from July 2026; held at least a year.
CMS note
64561 only when billed with 64590 (permanent implant); only for the indications in Appendix B.

What CMS lists for the record

From the WISeR Operational Guide, verbatim. The coverage policy governs; use the check below for the diagnosis and state.

CMS WISeR documentation checklist · §6.2.7

Operational Guide v7.0, last updated July 24, 2026 · retrieved 2026-09-14

Sacral Nerve Stimulation for Urinary Incontinence (NCD 230.18)

CMS: “To meet coverage criteria, the patient’s medical record must contain documentation that fully supports the medical necessity of services. Subsections 6.2.1 to 6.2.13 list the documentation requirements for example services. For detailed documentation requirements, providers who choose to submit a prior authorization request for a WISeR Select Item or Service should refer to the relevant NCDs and/or their MAC jurisdiction’s LCDs and Local Coverage Articles (LCAs), if available, for guidance. They can be found on the Medicare Coverage Database website.

Prior authorization and pre-payment review are being implemented for the permanent implantation procedure. A trial procedure should be done, and documentation should be submitted for permanent implantation of a stimulator device.17 Please note that lead replacement billed under CPT code 64561 does not require prior authorization or pre-payment review under WISeR, as NCD 230.18 does not explicitly address replacements. General documentation requirements for a permanently implanted sacral nerve stimulator for the treatment of urinary urge incontinence, urgency-frequency syndrome, or urinary retention are as follows:

  • Documentation of the relevant diagnosis (e.g., urge incontinence, urgency-frequency syndrome, or urinary retention) a) Of note, urinary voiding dysfunction should not be a secondary manifestation of specific neurologic diseases (e.g., diabetes with peripheral nerve involvement), stress incontinence, or urinary (e.g., bladder outlet) obstruction.
  • Documentation of treatments tried and failed (or contraindications), such as but not limited to: a) Behavioral therapy (e.g., bladder training, pelvic floor rehabilitation) b) Pharmacologic therapy c) Surgical corrective therapy (e.g., augmentation cystoplasty)
  • Documentation that the patient is capable of demonstrating adequate ability to record voiding diary data such that the clinical results of the implant procedure can be properly evaluated
  • Documentation that the patient had a successful test stimulation, as demonstrated by 50% or greater improvement (as measured through voiding diaries)
  1. [16] Prior authorization and pre-payment medical review for Sacral Nerve Stimulation for Urinary Incontinence will only be implemented for the indications specified in Appendix B.
  2. [17] During pre-payment review, the billing of a generator implantation code (CPT code 64590) will be used to differentiate between a trial and permanent implantation (billed using CPT code 64561).
Read the guide on CMS →

The coverage policy the reviewer applies, by state

Each state’s Medicare contractor writes its own LCD, so the policy that decides a 64581 request depends on the state. The documentation requirements below are quoted from the policy or its Billing & Coding article as captured; the linked CMS document is authoritative.

All WISeR states (AZ, NJ, OH, OK, TX, WA) · national coverage determination

NCD 230.18 — Sacral Nerve Stimulation For Urinary Incontinence · CMS version 1 · captured 2026-09-13

Read the documentation requirements in the linked CMS document.

Check 64581 for your state, diagnosis and setting

The governing policy as it stands today, whether the diagnosis is on its list, and the documentation the policy’s own text requires — quoted, source-linked, free.

Run the check →

Full lists: WISeR code list · WISeR rules and exemption

Same family: 64561

Sources: CMS WISeR Provider and Supplier Operational Guide v7.0 (2026-07-24), Appendix A; CMS list of OPD services requiring prior authorization (2024-08-05); CMS list of ambulatory surgical center services for prior authorization (2026-03-05) and the ASC Operational Guide (2026-03-03). Codes are shown as numbers only, as CMS lists them. CPT® is a registered trademark of the American Medical Association.